Cancer is the second leading cause of death in America, claiming nearly 572,000 lives last year alone. Characterized by uncontrolled cell growth and proliferation of abnormal cells, cancer—its causes, incidence, and treatments—remains confounding.
At Boston University’s Charles River and Medical Campuses, scientists and clinicians are piecing together the cancer puzzle from all angles—from decoding the basic science of what makes tumors grow to using proteins to target tumors to studying DNA and conducting epidemiological and population studies to determine who is most at risk and why.
At Boston Medical Center, Slone Epidemiology Center, the School of Public Health, the College of Arts & Sciences, and the College of Engineering, cancer research is an often groundbreaking multidisciplinary collaborative, with funding of approximately $41.2 million annually, much of it from the National Institutes of Health and its National Cancer Institute.
This week, BU Today presents “BU Takes On Cancer,” a five-part series examining the many ways BU researchers are working to demystify, treat, and prevent cancer.
Read about Professor Muhammad Zaman’s research in BU Today (written by Barbara Moran)